iAngels Ventures Fund I LP

www.iangels.com

Formerly iAngels iNgenuity I

Venture Capital Fund

Fully invested

Tech Verticals Preferences

AgriTech, Artificial Intelligence, Automotive, Biotechnology, Deep Tech, Digital Health, Enterprise Applications, Enterprise Software, Environment, FinTech, Healthtech, Industrial Technologies, MedTech

General Data

Management Company:	iAngels Ventures GP Ltd.
Vintage Year	2020
Current Active Portfolio Companies:	27
Reg. Number:	abCDe

DESCRIPTION

iAngels Ventures Fund is an early stage institutional fund, launched by iAngels. It specializes in early-stage, tech investments in Israel, in Enterprise Software, Fintech, AI, and Automotive. iNgenuity is backed by an anchor commitment from the European Investment Fund (EIF).

Related Funds

Fund Name	Fund Capital($m)	Status	Remarks
iAngels Ventures II	abCDe	Final Closing

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	18 Rothschild Blvd.
City	Tel Aviv
Country	Israel
Zip	6688121

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Ms. Shelly Hod-Moyal	General Partner

	CAPITAL RAISED

Date

Amount

Feb. 01, 2020

abCDe

Limited Partners	Type	Amount	Remarks
abC Defghij*	Investment Company	abCDe
abC Defghij	Government Fund	abCDe
abC Defghij	N/A	abCDe
abC Defghij	N/A	abCDe
abC Defghij	N/A	abCDe

Investment Data

Managed Capital	abCDe

Preferences

Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Enterprise Software & Infrastructure

52%

Digital Health

22%

Agritech

11%

Consumer-Oriented Software

Biomed

Cleantech

	PORTFOLIO COMPANIES

Current Portfolio Companies (27)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Amai Proteins

Agri

Series B	09/07/2023	N/A	$16m
Series A	07/07/2020	N/A	$12.3m

Antidote Health

Dig. Health

Series C	18/12/2024	N/A	$22m
Series B	31/08/2023	N/A	$7m
Series A	22/03/2022	N/A	$22m
Seed - Extended	25/08/2021	N/A	$5m
Seed - Extended	01/04/2021	N/A	$2m
Seed - Extended	23/01/2021	N/A	$4.2m

April

Ent. SW

Series B	23/07/2025	N/A	$38m
Series A	29/06/2022	N/A	$30m
Seed	18/12/2021	N/A	$10m

BeeHero

Agri

Series C	01/12/2024	N/A	$30m
Series B	01/12/2022	N/A	$42m
Series A	06/10/2021	N/A	$15m
Seed - Extended	28/05/2020	N/A	$4m

Bitmain

Ent. SW

Series C

07/08/2018

N/A

Brainvivo

Ent. SW

Series A	01/06/2021	N/A	$6.5m
Seed	01/10/2019	N/A	$1.5m

Clinch

Ent. SW

Series B

02/04/2021

N/A

$10m

CoinScan

CryptoHub offers a variety of high-quality, one-of-kind crypto trading tools and innovations to improve the average crypto trader's experience and safety when trading crypto. At CryptoHub, traders can utilize a range of resources, including a tool that performs sophisticated data analysis of every token on the blockchain, a smart contract builder, and launchpads.

CO SW

Seed

15/05/2023

N/A

$6.35m

GoArc

Ent. SW

Series B	01/01/2021	N/A	N/A
Series A - Extended	01/02/2020	N/A	N/A
Series A	01/10/2019	N/A	$8.5m

Guardz

Ent. SW

Series B	09/06/2025	N/A	$56m
Series A	13/12/2023	N/A	$18m
Seed	01/04/2022	N/A	$10m

Hello Heart

Dig. Health

Series D

02/05/2022

N/A

$70m

ImmunAI

Biomed

Series B	27/10/2021	N/A	$215m
Series A	11/02/2021	N/A	$60m
Seed - Extended	15/02/2020	N/A	$2.5m

Latica

Lynx is a developer of a medical platform, designed to unlock the potential of medical data and transform patient care. The company's platform shares clinical data securely for improved healthcare delivery and disruptive clinical research, while keeping patient privacy, enabling healthcare providers to facilitate secure and compliant collaborations for clinical and operational research.

Dig. Health

Seed - Extended	01/11/2024	N/A	N/A
Seed - Extended	13/12/2021	N/A	$9m

LeO

LeO is a developer of an artificial intelligence-powered commercial insurance prospecting data platform, designed to assist insurance assistance in answering insurance-related queries. The company's platform utilizes machine learning algorithms and investigates user behavior to automatically recommend insurance products that meet individual needs, while the AI algorithms can be used to automate time-consuming and paper-heavy processes and provide data-driven insights about customers, enabling insurance agencies to grow their business and save costs by launching proactive chatbots' campaigns and automating tedious customer service transactional operations.

Ent. SW

Seed - Extended

28/11/2021

$1.7m

$5m

Medorion

Dig. Health

Series B	12/09/2025	N/A	$5m
Series A	07/07/2021	N/A	$6m
Seed - Extended	01/08/2019	N/A	$2.4m

Nest Genomics

Nest is a provider of a healthcare platform, designed to provide automated health care plans to patients. The company uses data analytics to understand the genetic information of patients to predict any health risk, where the application can provide automatically generated personalized care plans for patients, enabling users to avoid any potential risk associated with health by following their genetics.

Dig. Health

Seed - Extended	15/12/2022	N/A	$8.5m
Seed	01/02/2022	$2m	$2m

NextDim

Ent. SW

Seed

01/01/2022

N/A

$3m

Payouts

Ent. SW

Seed - Extended	04/09/2024	N/A	$8m
Seed	01/06/2023	$4.1m	$4.1m

Quris

Dig. Health

Seed - Extended	30/07/2023	N/A	N/A
Seed - Extended	20/12/2022	N/A	$9m
Seed - Extended	30/12/2021	N/A	$19m

Reflectiz

Ent. SW

Series B	29/10/2025	N/A	$22m
Series A	14/12/2020	N/A	$5m

Seed-X

Agri

Series A

12/06/2022

N/A

$10m

Shuffll

Ent. SW

Seed

01/07/2023

N/A

Spinach AI

Spinach.io is fixing remote collaboration, starting with daily standups. The company's platform offers the required tools for virtual meetings and supports the remote product development team's work, thereby enabling businesses to keep things on track and focus on their growth.

Ent. SW

Seed

31/08/2021

N/A

$2.75m

Urecsys

Cln.

Series B	09/03/2022	N/A	$7m
Series A	14/04/2020	N/A	$7m

Viridian

Ent. SW

Seed

01/02/2022

N/A

$3.5m

Vyzer

CO SW

Seed

11/07/2022

N/A

$6.3m

WSC Sports

Ent. SW

Series D

15/02/2022

N/A

$100m

Exits (5)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	30/04/2026	abCDe
abC Defghij	Acquired	28/07/2025	abCDe
abC Defghij	IPO	19/07/2023	abCDe	In addition to the $61.4m raised directly by the company, existing shareholders Oran Holtzman and L Catterton sold their shares for $362.3m. ODDITY will not receive any proceeds from the sale of the shares by the selling shareholders.
abC Defghij	Acquired	12/08/2021	abCDe
abC Defghij	Acquired	18/05/2026	abCDe	Acqui-hire.

Historic Portfolio (2)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

InnovoPro

Suspendeed Operations

Agri

Series B

01/10/2020

N/A

$18m

myAir

Ceased to Operate

HW & Indust.

Seed - Extended	05/05/2021	N/A	$4m
Seed	01/02/2020	N/A	$2m

Last Updated:	abCDe
IVC Number:	abCDe